Navigation Links
Gaps in colorectal cancer screening persist between whites and non-whites
Date:2/18/2009

(SACRAMENTO, Calif.) Colorectal cancer screening among patients with Medicare coverage is increasing, but a persistent gap remains between whites who are screened most frequently and all other racial and ethnic groups, according to a new study by researchers at UC Davis and the University of Washington. The study also showed that the biggest gap is between whites and Hispanics.

Because Medicare covers all available colorectal cancer screening procedures, the research suggests that obstacles other than insurance coverage are responsible for these disparities.

"We need more information about the barriers that different populations encounter when it comes to screening for colon cancer," said Joshua Fenton, lead author of the study, which will appear in the March issue of the Journal of the American Geriatrics Society. "The issue clearly is not lack of access to health insurance. Socioeconomic, cultural and language barriers are all possibilities, but understanding which of these barriers is relevant for which group is essential to narrowing the gaps."

Fenton, a UC Davis assistant professor of family and community medicine, and his colleagues focused their analysis on a representative sample of nearly half a million patients aged 70 to 79 from four racial and ethnic groups: whites, blacks, Asians/Pacific Islanders and Hispanics. The data were compiled from a National Cancer Institute database that links Medicare claims with clinical information on cancer patients throughout the United States.

The researchers found that the percentage of patients with up-to-date colorectal cancer screenings rose for all groups from 1995 to 2003: from 39 percent to 47 percent for whites; 33 percent to 42 percent for Asians and Pacific Islanders; 29 percent to 38 percent for blacks; and 24 percent to 33 percent for Hispanics. Medicare initiated coverage for colorectal cancer screening in 1998. Nevertheless, the gaps between whites and other racial and ethnic groups have not narrowed.

Colorectal cancer struck an estimated 148,810 Americans in 2008 and killed 49,960. By detecting and removing precancerous polyps, screening can prevent colorectal cancer. The persistence of racial and ethnic disparities in screening points to the need for new research to elucidate why the disparities continue.

"Are white patients more likely to receive a doctor's recommendation than non-white patients? Are cultural or language barriers a major issue for patients in some communities? Do some patients have a harder time getting to the specialists who perform colonoscopy examinations? We need answers to questions like these in order to narrow racial and ethnic disparities in screening," Fenton said.

Fenton added that the study indicates the need for more outreach to encourage screening overall.

"Even though screening rates are increasing, they are not high enough - even among whites," he said. "Health systems need to make sure that doctors recommend screening and help patients follow through with recommended tests."


'/>"/>

Contact: Karen Finney
karen.finney@ucdmc.ucdavis.edu
916-734-9023
University of California - Davis - Health System
Source:Eurekalert

Related medicine news :

1. Direct Anesthetic Infusion Helps Colorectal Cancer Patients
2. The fight against colorectal cancer
3. Simple, personalized interventions improve colorectal cancer screening rates
4. Studies lend insights into colorectal cancer screening
5. Virtual colonoscopy -- a new technology for colorectal cancer screening?
6. Frequently Asked Questions When Considering a Colorectal Cancer Screening Test, From the American College of Gastroenterology
7. 18F-DG PET/CT can highly increase the detection of colorectal cancer
8. Colorectal cancer screening remains essential for elderly Americans
9. Racial and ethnic differences in colorectal cancer emphasize importance of screening
10. ASGE Applauds News of Drop in Colorectal Cancer Deaths
11. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... CO (PRWEB) , ... December 02, 2016 , ... Advanced ... announced it has appointed Jason Bice, CPA, MBA to serve as Advanced Inc.’s Chief ... for Advanced, Inc. , Jason brings extensive financial and operational leadership experience to ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... ... 02, 2016 , ... Mediaplanet’s newest campaign, “Digestive Heath,” hits ... proof that attitude and determination can combine into the most remarkable achievements. Over ... holidays. This campaign will offer patients a new-found hope, by seizing the opportunity ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is ... USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that ... “We are prolonging life 6 years in the last 3 decades,” says Dr. ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... veterinarian diagnostic imaging systems and the first company to offer robotic imaging ... Heart at their tradeshow booth # 941 for the American Association of Equine ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016 Lianluo Smart Limited ... "the Company") which develops, markets and sells medical ... China and international markets, recently ... and Treatment New Progress Forum, co-hosted by the ... Province , Guangdong Provincial People,s Hospital and ...
(Date:12/2/2016)... Dec. 1, 2016 The concept of rare diseases ... given to this sector has been taking shape in ... the political aspects and initiatives related to orphan medicinal products ... the level of member states individually. Many member states in ... the space of orphan medicinal products, the result of which ...
(Date:12/2/2016)... Allergan plc (NYSE: AGN ), a ... previously announced Accelerated Share Repurchase (ASR) Program. Logo - ... ... previously announced, the Company entered into a variable tenor ASR ... repurchase $10 billion of its ordinary shares. Approximately 40.5 million ...
Breaking Medicine Technology: